Wealth Invest AKL AlphaCura 0/50/100 W
Wealth Invest AKL AlphaCura 0/50/100 W operates in various business sectors.
Wealth Invest AKL AlphaCura 0/50/100 W (WEIACW) - Net Assets
Latest net assets as of : Dkr- DKK
Based on the latest financial reports, Wealth Invest AKL AlphaCura 0/50/100 W (WEIACW) has net assets worth Dkr- DKK as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Dkr-) and total liabilities (Dkr-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Dkr- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Wealth Invest AKL AlphaCura 0/50/100 W - Net Assets Trend (None–None)
This chart illustrates how Wealth Invest AKL AlphaCura 0/50/100 W's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Wealth Invest AKL AlphaCura 0/50/100 W (None–None)
The table below shows the annual net assets of Wealth Invest AKL AlphaCura 0/50/100 W from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Wealth Invest AKL AlphaCura 0/50/100 W's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Wealth Invest AKL AlphaCura 0/50/100 W Competitors by Market Cap
The table below lists competitors of Wealth Invest AKL AlphaCura 0/50/100 W ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
ROLLS-ROYCE HLDGS
MU:RRU
|
$147.17K |
|
Amphastar Pharmaceuticals Inc
STU:29A
|
$147.20K |
|
BioAdaptives Inc
PINK:BDPT
|
$147.23K |
|
Focus Home Interactive Société anonyme
STU:0HF
|
$147.49K |
|
R STAHL N
BE:RSL2
|
$147.02K |
|
MEDION
MU:MDN
|
$147.01K |
|
BASLER (BSL.SG)
STU:BSL
|
$146.96K |
|
Portfolioman Pet&Par SustWo KL
CO:PMIPPSW
|
$146.88K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Wealth Invest AKL AlphaCura 0/50/100 W's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Wealth Invest AKL AlphaCura 0/50/100 W's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Wealth Invest AKL AlphaCura 0/50/100 W utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Wealth Invest AKL AlphaCura 0/50/100 W's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Wealth Invest AKL AlphaCura 0/50/100 W (WEIACW) | Dkr- | N/A | N/A | $147.07K |
| Formuepleje Limittellus (FPILIM) | $596.00K | 19.33% | 0.00x | $368.96K |